BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20479422)

  • 1. Genetic testing in Li-Fraumeni syndrome: uptake and psychosocial consequences.
    Lammens CR; Aaronson NK; Wagner A; Sijmons RH; Ausems MG; Vriends AH; Ruijs MW; van Os TA; Spruijt L; Gómez García EB; Kluijt I; Nagtegaal T; Verhoef S; Bleiker EM
    J Clin Oncol; 2010 Jun; 28(18):3008-14. PubMed ID: 20479422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distress in partners of individuals diagnosed with or at high risk of developing tumors due to rare hereditary cancer syndromes.
    Lammens CR; Bleiker EM; Verhoef S; Ausems MG; Majoor-Krakauer D; Sijmons RH; Hes FJ; Gómez-García EB; Van Os TA; Spruijt L; van der Luijt RB; van den Ouweland AM; Ruijs MW; Gundy C; Nagtegaal T; Aaronson NK
    Psychooncology; 2011 Jun; 20(6):631-8. PubMed ID: 21384469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
    Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
    J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germ line BAX alterations are infrequent in Li-Fraumeni syndrome.
    Barlow JW; Mous M; Wiley JC; Varley JM; Lozano G; Strong LC; Malkin D
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1403-6. PubMed ID: 15298965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
    Gonzalez KD; Noltner KA; Buzin CH; Gu D; Wen-Fong CY; Nguyen VQ; Han JH; Lowstuter K; Longmate J; Sommer SS; Weitzel JN
    J Clin Oncol; 2009 Mar; 27(8):1250-6. PubMed ID: 19204208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
    Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA
    Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome.
    Wu CC; Shete S; Amos CI; Strong LC
    Cancer Res; 2006 Aug; 66(16):8287-92. PubMed ID: 16912210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Li-Fraumeni syndrome: update, new data and guidelines for clinical management].
    Frebourg T; Abel A; Bonaiti-Pellie C; Brugières L; Berthet P; Bressac-de Paillerets B; Chevrier A; Chompret A; Cohen-Haguenauer O; Delattre O; Feingold J; Feunteun J; Frappaz D; Fricker JP; Gesta P; Jonveaux P; Kalifa C; Lasset C; Leheup B; Limacher JM; Longy M; Nogues C; Oppenheim D; Sommelet D; Soubrier F; Stoll C; Stoppa-Lyonnet D; Tristant H
    Bull Cancer; 2001 Jun; 88(6):581-7. PubMed ID: 11459705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations.
    Finkova A; Vazna A; Hrachovina O; Bendova S; Prochazkova K; Sedlacek Z
    Cancer Genet Cytogenet; 2009 Aug; 193(1):63-6. PubMed ID: 19602465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychological distress and use of psychosocial support in familial adenomatous polyposis.
    Douma KF; Aaronson NK; Vasen HF; Gerritsma MA; Gundy CM; Janssen EP; Vriends AH; Cats A; Verhoef S; Bleiker EM
    Psychooncology; 2010 Mar; 19(3):289-98. PubMed ID: 19382100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome.
    Tabori U; Nanda S; Druker H; Lees J; Malkin D
    Cancer Res; 2007 Feb; 67(4):1415-8. PubMed ID: 17308077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regular surveillance for Li-Fraumeni Syndrome: advice, adherence and perceived benefits.
    Lammens CR; Bleiker EM; Aaronson NK; Wagner A; Sijmons RH; Ausems MG; Vriends AH; Ruijs MW; van Os TA; Spruijt L; Gómez García EB; Cats A; Nagtegaal T; Verhoef S
    Fam Cancer; 2010 Dec; 9(4):647-54. PubMed ID: 20658357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 Germline mutation in a patient with Li-Fraumeni Syndrome and three metachronous malignancies.
    Pötzsch C; Voigtländer T; Lübbert M
    J Cancer Res Clin Oncol; 2002 Aug; 128(8):456-60. PubMed ID: 12200603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New knowledge of Li-Fraumeni syndrome].
    Funato M; Kondo N
    Gan To Kagaku Ryoho; 2013 Feb; 40(2):148-53. PubMed ID: 23411951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.
    Birch JM; Blair V; Kelsey AM; Evans DG; Harris M; Tricker KJ; Varley JM
    Oncogene; 1998 Sep; 17(9):1061-8. PubMed ID: 9764816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families.
    Achatz MI; Olivier M; Le Calvez F; Martel-Planche G; Lopes A; Rossi BM; Ashton-Prolla P; Giugliani R; Palmero EI; Vargas FR; Da Rocha JC; Vettore AL; Hainaut P
    Cancer Lett; 2007 Jan; 245(1-2):96-102. PubMed ID: 16494995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Li-Fraumeni syndrome].
    Tsunematsu Y
    Nihon Rinsho; 2000 Jul; 58(7):1442-7. PubMed ID: 10921321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germ-line mutations of TP53 in Li-Fraumeni families: an extended study of 39 families.
    Varley JM; McGown G; Thorncroft M; Santibanez-Koref MF; Kelsey AM; Tricker KJ; Evans DG; Birch JM
    Cancer Res; 1997 Aug; 57(15):3245-52. PubMed ID: 9242456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Easing the Burden: Describing the Role of Social, Emotional and Spiritual Support in Research Families with Li-Fraumeni Syndrome.
    Peters JA; Kenen R; Bremer R; Givens S; Savage SA; Mai PL
    J Genet Couns; 2016 Jun; 25(3):529-42. PubMed ID: 26621765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of de novo mutations in Li-Fraumeni syndrome.
    Gonzalez KD; Buzin CH; Noltner KA; Gu D; Li W; Malkin D; Sommer SS
    J Med Genet; 2009 Oct; 46(10):689-93. PubMed ID: 19556618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.